This result may translate into the fact that the French medical teams did not comply with the Milan criteria (since in the MilanCP period only 65.8% were in the MC on the explant considering viable tumor and only 54.6% considering total volume), but they intuitively anticipated AFP model application. This evidence concerns the gene AFP and neoplasm.